Merck KGaA, Eppendorf AG, and SGS SA were dominating the Global Cell and Gene Therapy Thawing Equipment Market in 2020

Global Cell and Gene Therapy Thawing Equipment is expected to grow with the CAGR of 6.7% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @

Global cell and gene therapy thawing equipment is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global cell and gene therapy thawing equipment are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced reprocessed services and product portfolio.

For instance, In October 2020, Merck KGaA, had launched the VirusExpress Lentiviral Production Platform. The rise of the Virus Express Lentiviral Production Platform would result in overcoming the challenges in lentiviral production, and reducing the process development by 40% and would provide lucrative opportunities for curative treatments.

Merck KGaA is the dominating player in global cell and gene therapy thawing equipment market. The other key players existing in the market are Cytiva (A subsidiary of Danaher Corporation), Pluristem Therapeutics Inc., Genesis BPS, Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, BIOLINE INDIA and Helmer Scientific Inc. among others.

Cell and Gene Therapy Thawing Equipment Market Merck KGaA

Merck KGaA has it base headquarters in Darmstadt, Germany. The company is focused on providing solutions, in the field of healthcare, Life Science and performance materials, with passion for technology and love for Science. The company deals in product categories Endocrinology, Neurology, Pharma Biotech, Display Solutions, Automotive out of which Pharma Biotech is the market focused market focused segment.

  • In April 2020, Merck KGaA had expanded the Commercial Viral Vector and Gene Therapy Manufacturing Capacity in the U.S. The expansion resulted in increasing the production capacity twice and would pave the opportunity for biopharmaceuticals.

The company has presence in Latin America, North America, Europe, Asia, Oceania and Africa.

Eppendorf AG

Eppendorf AG is headquartered in Hamburg, Germany and was founded in 1945. The aim of the company is to develop and sell instruments, consumables and services, for liquid, sample and cell handling laboratories worldwide. Temperature control and Mixing is the market focused category.

  • In August 2020, Eppendorf AG had conducted a virtual lab exhibition for biotechnology instruments and consumables. This would result in increased awareness about the use of thawing instruments.

The company has wide global presence across North America Europe, Asia Pacific, and Europe. The company has various subsidiaries which are USA Scientific Inc (U.S.), Eppendorf North America (North America), and DASGIP among others.


SGS SA is headquartered in Gottingen, Germany and was founded in year 1870. The company is focusing on the biopharmaceutical industry and the research sector.  The market focused segment is the Bioprocess Solutions. The company offers wide range of product in various categories such as Flow Cytometry, Industrial Microbiology, and Fluid Management out of which Fluid Management is market focused category.     

  • In May 2020, SGS SA has expanded the Network of ISTA Labs and Adds ISTA’s 6-Amazon Certification Testing. The service expansion meant to maintain the package testing standards while outsourcing the medical devices and the need to protect products from damage throughout the supply chain without the need for additional packaging.

The company has wide global presence across the world in Europe, North America, Asia Pacific, Middle East and Africa. The subsidiaries are Sartorius Stedim Belgium NV, Sartorius Stedim Biotech GmbH among others.